RxDoctor Payments Data

Steven Tucker, MD

Family Medicine · Manassas, VANPI 1952416612

Payments from drug & device makers

$472in general payments, 2019–2025

Across 27 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$237
  • Novo Nordisk$165
  • Amgen$23
  • Merck$17
  • Lilly USA, LLC$16
  • Johnson & Johnson$14

What the payments were for

  • Food & beverage$472100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca13$237
Novo Nordisk10$165
Amgen1$23
Merck1$17
Lilly USA, LLC1$16
Johnson & Johnson1$14

How this compares

$472 in reported general payments places this provider in the 55th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$81,271
Medicare patients
88
Services billed
915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate15$24,521
MounjaroTirzepatide13$12,209
VascepaIcosapent Ethyl12$4,596
Irbesartan48$1,403
Atorvastatin Calcium204$1,163
NovologInsulin Aspart12$831
Rosuvastatin Calcium59$594
Levothyroxine Sodium63$582
Losartan Potassium86$509
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$433
Amlodipine Besylate128$386
Valsartan11$368
Sertraline Hcl34$367
Acetaminophen-CodeineAcetaminophen With Codeine25$341
Metformin Hcl ErMetformin Hcl54$317

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$17$24,52115 claims
Lilly USA, LLCMounjaro$16$12,20913 claims
Novo NordiskNovolog$165$83112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →